betamethasone + fusidic acid


LEO Pharma


Concise Prescribing Info
Per g Fusidic acid 20 mg, betamethasone valerate 1 mg
Inflammatory dermatoses (including atopic eczema, discoid eczema, stasis eczema, seborrhoeic dermatitis, contact dermatitis, lichen simplex chronicus, psoriasis, discoid lupus erythematosus) where bacterial infection is present or likely to occur.
Dosage/Direction for Use
Uncovered lesions Apply bd-tds. Covered lesions Less frequent application may be adequate.
Hypersensitivity. Systemic fungal infections; primary fungal, viral or bacterial skin infections, either untreated or uncontrolled by appropriate treatment; skin manifestations in relation to TB, either untreated or uncontrolled by appropriate treatment; perioral dermatitis & rosacea.
Special Precautions
Avoid long-term continuous topical therapy; contact to eyes; large amounts & occlusion; contact w/ open wounds & mucous membranes; applying on the breast. Limit therapy to no more than 14 days at a time to minimise risk of developing resistance. May be associated w/ increased susceptibility to infection, aggravation of existing infection, & activation of latent infection. Contains cetostearyl alcohol & chlorocresol. Pregnancy. Childn. Fusidic acid: Reports of bacterial resistance. Betamethasone valerate: Always consider possible systemic absorption during treatment. Reports of visual disturbance. Risk of reversible hypothalamic-pituitary-adrenal (HPA) axis suppression following systemic absorption. Risk of atrophic changes on the face after prolonged treatment. Risk of raised IOP & glaucoma after use near the eyes, particularly w/ prolonged use & in patients predisposed to developing glaucoma.
MIMS Class
Topical Anti-Infectives with Corticosteroids
ATC Classification
D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent (group III) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.
Fucicort cream
15 g x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in